Uveitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The condition affects both eyes.
- There are at least three specific spots (called "birdshot lesions") below or to the inner side of the optic nerve in at least one eye.
- There is only a small amount of inflammation in the front part of the eye (a low level, confirmed by an eye exam).
- There is only a mild level of cloudiness or inflammation in the jelly-like fluid inside the eye (a low level, confirmed by an eye exam).
The following findings may also support eligibility (confirm with trial site):
- A positive result for a specific genetic marker called HLA-A29.
- Inflammation of the blood vessels in the retina.
- Swelling in the central part of the retina (the macula).
Who may not be able to join:
- There are deposits on the inner surface of the cornea (the clear front part of the eye), known as keratic precipitates.
- There is scarring that causes the iris (the colored part of the eye) to stick to the lens inside the eye.
- There is another condition present — such as an infection, a cancer-related condition, or a different inflammatory disease — that could cause similar-looking spots in the eye.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Antoine BREZIN, PhD & MD, Université de Paris, Ophtalmopôle, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris.
Phone: +33 1 58412898
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Best Corrected Visual Acuity (BCVA); Visual field testing; Color vision; National Eye Institute 25-Item Visual Function Questionnaire
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.